Literature DB >> 9267904

Severe fetal malformations associated with trisomy 16 confined to the placenta.

J M Sánchez1, S López De Díaz, M J Panal, G Moya, A Kenny, D Iglesias, J Wolstenholme.   

Abstract

Chorionic villus sampling (CVS) and amniocentesis were performed on a pregnant woman during her 24th week of amenorrhoea following an ultrasound scan which showed a fetus with hydrocephaly, intrauterine growth retardation (IUGR), and a single umbilical artery. The direct karyotype from the cytotrophoblast was non-mosaic 47,XXX,+16, while in amniotic fluid and several fetal tissues, studied post-mortem, a normal 46,XX karyotype was found in more than 400 cells. Uniparental disomy (UPD) was excluded by molecular genetic studies. Autopsy confirmed the echographic findings; in addition, agenesis of the corpus callosum and polysplenia were observed. This is the second example of congenital abnormality associated with confined placental mosaicism (CPM) for trisomy 16, without evidence of either UPD or an apparent contribution of abnormal cells to the fetus.

Entities:  

Mesh:

Year:  1997        PMID: 9267904     DOI: 10.1002/(sici)1097-0223(199708)17:8<777::aid-pd128>3.0.co;2-h

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes?

Authors:  Teresa N Sparks; Kao Thao; Mary E Norton
Journal:  Genet Med       Date:  2017-04-06       Impact factor: 8.822

2.  Intrauterine growth retardation fetus with trisomy 16 mosaicism.

Authors:  Takol Chareonsirisuthigul; Suchin Worawichawong; Rachanee Parinayok; Patama Promsonthi; Budsaba Rerkamnuaychoke
Journal:  Case Rep Genet       Date:  2014-05-14

3.  Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes.

Authors:  Tamara Mossfield; Erica Soster; Melody Menezes; Gloudi Agenbag; Marie-Line Dubois; Jean Gekas; Tristan Hardy; Monika Jurkowska; Pascale Kleinfinger; Kelly Loggenberg; Pablo Marchili; Roberto Sirica
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.